IP Library Patent Application 17868141
Patent Application
App. No. 17/868,141

METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/868,141
Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

Claims (26)

1 . A method for enriching and sequencing cell-free DNA, comprising:

tagging cell-free DNA isolated from a biological sample with molecular barcodes to obtain a library of DNA, wherein the cell-free DNA from a single biological sample are tagged with a plurality of molecular barcodes;

amplifying the library of DNA and enriching for a plurality of target loci using a plurality of target-specific hybrid capture probes to obtain an enriched library of amplicons, wherein at least one amplicon comprises two or more target loci; and

performing high-throughput sequencing to sequence the amplicons to obtain sequence reads of at least 50 target loci and determine whether the target loci comprise a cancer-associated mutation based on the sequence reads.

2 . The method of claim 1 , wherein the biological sample is a blood, plasma, serum, or urine sample.

3 . The method of claim 1 , wherein at least one amplicon comprises two or more nearby single nucleotide polymorphism or variant loci.

4 . The method of claim 1 , wherein the plurality of target loci comprises between 100 and 2,000 single nucleotide polymorphism or variant loci.

5 . The method of claim 1 , wherein the plurality of target loci comprises between 200 and 1,000 single nucleotide polymorphism or variant loci.

6 . The method of claim 1 , wherein the plurality of target loci comprises between 300 and 2,000 single nucleotide polymorphism or variant loci.

7 . The method of claim 1 , wherein the cell-free DNA are tagged with up to 1024 molecular barcodes.

8 . The method of claim 1 , wherein the cell-free DNA are tagged with 1024-65536 molecular barcodes.

9 . The method of claim 1 , wherein the cell-free DNA are tagged with the molecular barcodes through adaptor ligation.

10 . The method of claim 1 , wherein sequence reads originating from the same original molecule are identified using the molecular barcodes.

11 . A method for enriching and sequencing cell-free DNA, comprising:

tagging cell-free DNA isolated from a biological sample with molecular barcodes to obtain a library of DNA, wherein the cell-free DNA from a single biological sample are tagged with a plurality of molecular barcodes;

enriching the library of DNA for a plurality of target loci using a plurality of target-specific hybrid capture probes and amplifying the target loci to obtain an enriched library of amplicons, wherein at least one amplicon comprises two or more target loci; and

performing high-throughput sequencing to sequence the amplicons to obtain sequence reads of at least 50 target loci and determine whether the target loci comprise a cancer-associated mutation based on the sequence reads.

12 . The method of claim 11 , wherein the biological sample is a blood, plasma, serum, or urine sample.

13 . The method of claim 11 , wherein at least one amplicon comprises two or more nearby single nucleotide polymorphism or variant loci.

14 . The method of claim 11 , wherein the plurality of target loci comprises between 100 and 2,000 single nucleotide polymorphism or variant loci.

15 . The method of claim 11 , wherein the plurality of target loci comprises between 200 and 1,000 single nucleotide polymorphism or variant loci.

16 . The method of claim 11 , wherein the plurality of target loci comprises between 300 and 2,000 single nucleotide polymorphism or variant loci.

17 . The method of claim 11 , wherein the cell-free DNA are tagged with up to 1024 molecular barcodes.

18 . The method of claim 11 , wherein the cell-free DNA are tagged with 1024-65536 molecular barcodes.

19 . The method of claim 11 , wherein the cell-free DNA are tagged with the molecular barcodes through adaptor ligation.

20 . The method of claim 11 , wherein sequence reads originating from the same original molecule are identified using the molecular barcodes.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2026
From: GEMELOS, GEORGE; HILL, MATTHEW; RABINOWITZ, MATTHEW; SIGURJONSSON, STYRMIR; ZIMMERMAN, BERNHARD
To: NATERA, INC.
Reel/Frame 075229/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2026
From: GENE SECURITY NETWORK INC.
To: NATERA, INC.
Reel/Frame 075229/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2026
From: BANER, JOHAN; BANJEVIC, MILENA; RYAN, ALLISON; DEMKO, ZACHARY
To: GENE SECURITY NETWORK, INC.
Reel/Frame 075229/0309 →